A Sub Study to Learn About the Study Medication Called Etrasimod Tablets in a Hybrid Decentralized Clinical Trial Setting

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508119-22-00

Acronym

C5041050

Enrollment

Registered

2023-10-26

Start date

2023-12-18

Completion date

2024-03-01

Last updated

2024-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alopecia areata, and eosinophilic esophagitis, atopic dermatitis, immune-mediated inflammatory disorders, including ulcerative colitis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026